Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle

per Marchetti, Antonio, Di Lorito, Alessia, Buttitta, Fiamma
Publicat a J Thorac Dis (2017)

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments

per Marchetti, Antonio, Di Lorito, Alessia, Felicioni, Lara, Buttitta, Fiamma
Publicat a Oncotarget (2019)

MicroRNAs derived from circulating exosomes as non-invasive biomarkers for screening and diagnose lung cancer

per Cazzoli, Riccardo, Buttitta, Fiamma, Di Nicola, Marta, Malatesta, Sara, Marchetti, Antonio, Pass, Harvey I.
Publicat 2013

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report

per Gambale, Elisabetta, Carella, Consiglia, Amerio, Paolo, Buttitta, Fiamma, Patea, Rosa Lucia, Natoli, Clara, De Tursi, Michele
Publicat a Int Med Case Rep J (2017)

Survival prediction of stage I lung adenocarcinomas by expression of 10 genes

per Bianchi, Fabrizio, Nuciforo, Paolo, Vecchi, Manuela, Bernard, Loris, Tizzoni, Laura, Marchetti, Antonio, Buttitta, Fiamma, Felicioni, Lara, Nicassio, Francesco, Di Fiore, Pier Paolo
Publicat 2007

Mutational Profile of GNAQ (Q209) in Human Tumors

per Lamba, Simona, Felicioni, Lara, Buttitta, Fiamma, Bleeker, Fonnet E., Malatesta, Sara, Corbo, Vincenzo, Scarpa, Aldo, Rodolfo, Monica, Knowles, Margaret, Frattini, Milo, Marchetti, Antonio, Bardelli, Alberto
Publicat 2009

Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer()()

per Gasparini, Giampietro, Buttitta, Fiamma, D'Andrea, Mario Rosario, Tumolo, Salvatore, Buonadonna, Angela, Pavese, Ida, Cordio, Stefano, De Tursi, Michele, Mosconi, Stefania, Stumbo, Luciano, Felicioni, Lara, Marchetti, Antonio
Publicat a Neoplasia (2014)

Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications

per Marchetti, Antonio, Del Grammastro, Maela, Filice, Giampaolo, Felicioni, Lara, Rossi, Giulio, Graziano, Paolo, Sartori, Giuliana, Leone, Alvaro, Malatesta, Sara, Iacono, Michele, Guetti, Luigi, Viola, Patrizia, Mucilli, Felice, Cuccurullo, Franco, Buttitta, Fiamma
Publicat 2012

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

per Marchetti, Antonio, Del Grammastro, Maela, Felicioni, Lara, Malatesta, Sara, Filice, Giampaolo, Centi, Irene, De Pas, Tommaso, Santoro, Armando, Chella, Antonio, Brandes, Alba Ariela, Venturino, Paola, Cuccurullo, Franco, Crinò, Lucio, Buttitta, Fiamma
Publicat 2014

MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway

per Mancini, Francesca, Di Conza, Giusy, Pellegrino, Marsha, Rinaldo, Cinzia, Prodosmo, Andrea, Giglio, Simona, D'Agnano, Igea, Florenzano, Fulvio, Felicioni, Lara, Buttitta, Fiamma, Marchetti, Antonio, Sacchi, Ada, Pontecorvi, Alfredo, Soddu, Silvia, Moretti, Fabiola
Publicat 2009

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record

per Pagni, Fabio, Malapelle, Umberto, Doglioni, Claudio, Fontanini, Gabriella, Fraggetta, Filippo, Graziano, Paolo, Marchetti, Antonio, Guerini Rocco, Elena, Pisapia, Pasquale, Vigliar, Elena V., Buttitta, Fiamma, Jaconi, Marta, Fusco, Nicola, Barberis, Massimo, Troncone, Giancarlo
Publicat a Cancers (Basel) (2020)

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

per Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D’Orazio, Carla, Dal Mas, Antonella, Calvisi, Giuseppe, Giordano, Aldo V, Vicentini, Vincenzo, Vicentini, Roberto, Felicioni, Lara, Marchetti, Antonio, Buttitta, Fiamma, Russo, Antonio, Ficorella, Corrado
Publicat a Onco Targets Ther (2019)

Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones

per Marchetti, Antonio, Milella, Michele, Felicioni, Lara, Cappuzzo, Federico, Irtelli, Luciana, Del Grammastro, Maela, Sciarrotta, Mariagrazia, Malatesta, Sara, Nuzzo, Carmen, Finocchiaro, Giovanna, Perrucci, Bruno, Carlone, Donatella, Gelibter, Alain J, Ceribelli, Anna, Mezzetti, Andrea, Iacobelli, Stefano, Cognetti, Francesco, Buttitta, Fiamma
Publicat 2009

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

per Cappuzzo, Federico, Marchetti, Antonio, Skokan, Margaret, Rossi, Elisa, Gajapathy, Sujatha, Felicioni, Lara, del Grammastro, Maela, Sciarrotta, Maria Grazia, Buttitta, Fiamma, Incarbone, Matteo, Toschi, Luca, Finocchiaro, Giovanna, Destro, Annarita, Terracciano, Luigi, Roncalli, Massimo, Alloisio, Marco, Santoro, Armando, Varella-Garcia, Marileila
Publicat 2009

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

per Buttitta, Fiamma, Felicioni, Lara, Lorito, Alessia Di, Cortellini, Alessio, Irtelli, Luciana, Brocco, Davide, Marino, Pietro Di, Traisci, Donatella, D’Ostilio, Nicola, Paolo, Alessandra Di, Malorgio, Francesco, Assalone, Pasquale, Felice, Sonia Di, Fabbri, Francesca, Cianci, Giovanni, Tursi, Michele De, Marchetti, Antonio
Publicat a Oncotarget (2020)

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

per Capoluongo, Ettore, La Verde, Nicla, Barberis, Massimo, Bella, Maria Angela, Buttitta, Fiamma, Carrera, Paola, Colombo, Nicoletta, Cortesi, Laura, Genuardi, Maurizio, Gion, Massimo, Guarneri, Valentina, Lorusso, Domenica, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pensabene, Matilde, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Sapino, Anna, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Trevisiol, Chiara, Truini, Mauro, Varesco, Liliana, Russo, Antonio, Gori, Stefania
Publicat a Diagnostics (Basel) (2019)

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

per Lin, Luping, Sabnis, Amit J, Chan, Elton, Olivas, Victor, Cade, Lindsay, Pazarentzos, Evangelos, Asthana, Saurabh, Neel, Dana, Yan, Jenny Jiacheng, Lu, Xinyuan, Pham, Luu, Wang, Mingxue M, Karachaliou, Niki, Cao, Maria Gonzalez, Manzano, Jose Luis, Ramirez, Jose Luis, Torres, Jose Miguel Sanchez, Buttitta, Fiamma, Rudin, Charles M, Collisson, Eric A, Algazi, Alain, Robinson, Eric, Osman, Iman, Muñoz-Couselo, Eva, Cortes, Javier, Frederick, Dennie T, Cooper, Zachary A, McMahon, Martin, Marchetti, Antonio, Rosell, Rafael, Flaherty, Keith T, Wargo, Jennifer A, Bivona, Trever G
Publicat a Nat Genet (2015)